...A status report of each postmarketing study of the drug product concerning clinical safety.....FDA will maintain a requirement for reporting data from all ongoing product stability studies.....FDA's current guidance for industry states that data accumulated from ongoing stability..
http://www.fda.gov/OHRMS/DOCKETS/98fr/103000c.htm (score=100)
HUMAN DRUG CGMP NOTES March 1998
...This means that even though a drug product is not sterile, a firm must follow written.....For example, microbial content that adversely affects product stability, would be.....Therefore, a quality control unit could be a corporation external to the drug product..
http://www.fda.gov/cder/hdn/cnotes38.htm (score=83)
HUMAN DRUG CGMP NOTES, June 1997
...Because in large containers dosage units near the closure may have different stability.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....The nature and extent of end product testing beyond potency should be determined by the..
http://www.fda.gov/cder/hdn/cnotes67.htm (score=73)
MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=66)
...Since an ANDA applicant must demonstrate that the generic drug product exhibits adequate.....The drug substance in a generic drug product is considered to be the same as the drug substance in the RLD if it meets the.....The extent of conversion generally depends on the relative stability of the polymorphs..
http://www.fda.gov/cder/guidance/6154dft.doc (score=57)
Scientific Positions within Office of Pharmaceutical Science
...Review and evaluate manufacturing procedures, microbiology protocols and data regarding drug.....product stability information. In addition to this review role, the Office of Testing and Research.....Their primary function is the review of microbiological aspects of drug manufacturing to..
http://www.fda.gov/cder/OPS/positions.htm (score=55)
Guidanc for Industry: Container and Closure Integrity Testing in Lieu of...
...testing of drugs, and provides a general indication of the information on product.....ICH final guideline is intended to supplement the tripartite ICH guideline entitled, "Stability..Testing of New Drug.....product varies with time under the influence of a variety of environmental factors such as..
http://www.fda.gov/cber/gdlns/contain.pdf (score=52)
Reporting Adverse Reactions and Other Product Problems
...After being treated at the hospital, he contacted the local Food and Drug Administration.....Yet some problems can remain unknown, only to be discovered when a product is used by a.....Describe the product as completely as possible, including any codes or identifying marks..
http://www.fda.gov/fdac/features/1998/698_mail.html (score=51)
ICH; Guidance for Industry Q1D Bracketing and Matrixing Designs for...
...When a secondary packaging system contributes to the stability of the drug product, matrixing can be performed.....The differences in the samples for the same drug product should be identified as, for example.....Data variability and product stability, as shown by supporting data, should be considered when a..
http://www.fda.gov/cber/gdlns/ichq1d.htm (score=51)
Draft Guidance for Industry: Drugs, Biologics and Medical Devices Derived...
...information on the stability of the final product and any in-process material at each.....address during the investigation of a new animal drug and preparation of an.....conditions and verification of its stability under the conditions described should be..
http://www.fda.gov/OHRMS/DOCKETS/98fr/02d-0324-gdl0001.pdf (score=51)
Draft Guidance for Industry: Drugs, Biologics and Medical Devices Derived...
...information on the stability of the final product and any in-process material at each.....address during the investigation of a new animal drug and preparation of an.....conditions and verification of its stability under the conditions described should be..
http://www.fda.gov/cber/gdlns/bioplant.pdf (score=51)
þÿ
...differences in the samples for the same drug product should be identified as, for example.....When a secondary packaging system contributes to the stability of the drug product.....that the stability of any intermediate levels is represented by the stability of the..
http://www.fda.gov/cber/gdlns/ichq1d.pdf (score=51)
stability guidance -draft
...Significant change for a drug product at the accelerated stability condition and the.....this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....satisfactory product stability, which may in turn include, but not be limited to, full long-term..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=51)
6003dft.doc
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....therefore, real-time concurrent stability studies on the product potentially affected by.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=48)
Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....Generally, therefore, real-time concurrent stability studies on the product potentially.....Therefore, it might be appropriate to collect data on the drug product to support the..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=47)
International Conference on Harmonisation; Draft Guidance on Q5E...
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....therefore, real-time concurrent stability studies on the product potentially affected by.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=46)
/a//content.14388
...Mixing, granulating, milling, molding, of components, drug product containers, formulating.....whether they use terminal sterilization, three initial batches in the stability.. Sampling.....Therefore, under the Federal Food, all established standards, specifications, Drug, and..
http://www.fda.gov/cder/dmpq/fr5396.pdf (score=45)
Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and.....the evidence derived from validation studies which assures that product identity, purity, potency, and stability is preserved for.....This section should contain information on the stability of the drug substance and any in..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=42)
Human Drug Notes
...65 require that equipment used in processing of a drug product be suitable for its intended use.....In the latter case, until appropriate stability data is generated, the expiration date.....drug product, stability studies should be conducted according to an approved stability protocol..
http://www.fda.gov/cder/hdn/hdn1295.htm (score=41)
Guidance for Industry: Drug Product: Chemistry, Manufacturing, and Controls...
...Such data can include, for example, stability data on small scale batches of drug product, investigational formulations not.....If drug substance and drug product information is provided in an appendix, the preferred presentation is drug.....Constitution or dilution studies performed as part of formal stability studies to confirm..
http://www.fda.gov/cber/gdlns/drugcmc.htm (score=39)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer